The Alaska Supreme Court has ruled in favor of the State of Alaska in its lawsuit against several major pharmacies, including Albertsons, Safeway, and Kroger, over their alleged role in the opioid epidemic. The court's decision, filed on November 6, 2026, allows the state to pursue claims of public nuisance against the pharmacies, which could have significant implications for public health and safety.

The case, docketed as S-19048, centers on the state's allegations that these pharmacies contributed to the opioid crisis by failing to monitor and report suspicious prescriptions, thereby facilitating opioid misuse and addiction. This ruling comes as the opioid epidemic continues to affect communities across Alaska, leading to increased healthcare costs and social issues.

Background

The parties involved in this case include the State of Alaska, represented by Attorney General Treg Taylor and Senior Assistant Attorney General Laura Fox, and several major pharmacy chains, including Albertsons Companies, Inc., Safeway, and Kroger. The State alleges that these pharmacies failed to uphold their legal responsibilities under federal and state drug laws, contributing to a public health crisis.

The opioid epidemic has had devastating effects on Alaskan society, with rising rates of addiction, overdose deaths, and related healthcare costs. The state claims that the pharmacies ignored their duties to monitor and report suspicious prescriptions, which has led to widespread opioid misuse. The case was initially dismissed by a lower court, which ruled that the pharmacies' actions did not amount to a public nuisance and that their conduct was exempt from the Alaska Unfair Trade Practices and Consumer Protection Act (UTPA).

The Ruling

The Alaska Supreme Court reversed the lower court's decision regarding the public nuisance claim, allowing the state to proceed with its lawsuit. In the opinion written by Justice Pate, the court stated, "the pharmacies’ failure to fulfill their legal obligations when dispensing opioids unreasonably interfered with public rights protected by the common law." The court emphasized that the state had sufficiently articulated its claims to survive a motion to dismiss.

However, the court upheld the lower court's dismissal of the UTPA claims, affirming that the pharmacies' conduct was largely exempt from the UTPA due to their regulation under state and federal law. The ruling noted that while the pharmacies are subject to careful regulation, the state did allege one unfair or deceptive act that was not specifically prohibited by state regulations, which led to the partial reversal of the dismissal.

Impact

This ruling is significant as it revives the state's public nuisance claim, allowing it to argue that the pharmacies' actions have contributed to a widespread public health crisis. The court's decision underscores the responsibility of pharmacies to monitor and control the distribution of prescription opioids, which could set a precedent for similar cases in other jurisdictions.

With the opioid crisis continuing to strain healthcare systems and communities, this case could lead to increased accountability for pharmacies and potentially result in changes to how they operate. The ruling may encourage other states to pursue similar claims against pharmacies and pharmaceutical companies, emphasizing the need for stricter oversight and compliance with drug laws.

What's Next

The pharmacies may seek to appeal the ruling, particularly regarding the public nuisance claim. Additionally, the case may lead to further legal battles as the state seeks remedies for the public health impacts of the opioid epidemic. Details regarding any potential appeals or related cases were not available in the court filing.